Atlas Trials

Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer

Clinical trial NCT00032123 · COMPLETED

Trial details

NCT number
NCT00032123
Sponsor
SWOG Cancer Research Network
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Esophageal CancerGastric Cancer
Start date
2002-06-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.